Patients
This site is intended for Medical Professionals and Patients outside of the United States and Japan
Medical Professionals Patients


on page  professionals

cookies testcookie=ack;
bot 1
cookie len 15
browser ccbot/1.0 (+http://www.commoncrawl.org/bot.html)

For Medical Professionals

For Medical Professionals

Hyperprolactinaemia (hyperprolactinemia) is a condition where excess levels of the hormone prolactin are found in the blood. This can cause symptoms including irregular or absent menstrual cycles, infertility and increased production of breast milk.

NORPROLAC (quinagolide) is the selective D2 receptor agonist that offers improved tolerability compared to bromocriptine1. NORPROLAC can effectively and rapidly reduce elevated prolactin levels to correct the signs and symptoms associated with this condition.

  
Suggest the benefits of registering:
E-MAIL A COLLEAGUE

Understanding the aetiology and evaluation of hyperprolactinaemia. J. Calaf, Spain

Clinical implications of hyperprolactinaemia in the short-and long-term. A. Genazzani,  Italy

The benefits and challenges of dopamine agonist therapy in the treatment of hyperprolactinaemia. A-L. Hulting, Sweden

Stay current with news related to hyperprolactinaemia.

Notification of new online presentations.

Receive updates when new information is added to NORPROLAC.com.
Presented in Athens, Greece on 16 April 2005 at:
 

 

1. van der Heijden PF, Lappohn RE, Corbey RS, et al. The effectiveness, safety, and tolerability of CV 205-502 in hyperprolactinemic women: a 12-month study. Fertil Steril 1989;52:574–579.
 
Ferring.com | Disclaimer | About Ferring
© 2005 Ferring Pharmaceuticals. All rights reserved.
NOR002